UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

Diabetes (New York, N.Y.), 2002-02, Vol.51 (suppl 1), p.S117-S121

GERICH, John E

2002

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens

Diabetes (New York, N.Y.), 2003-04, Vol.52 (4), p.918-925

2003

Link zum Volltext

Verfügbarkeit prüfen

Disturbances in β-Cell Function in Impaired Fasting Glycemia

Diabetes (New York, N.Y.), 2002-02, Vol.51 (suppl 1), p.S265-S270

2002

Link zum Volltext

Verfügbarkeit prüfen

Role of the human kidney in glucose counterregulation

Diabetes (New York, N.Y.), 1999-05, Vol.48 (5), p.943

1999

Link zum Volltext

Verfügbarkeit prüfen

Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: Further evidence for hepatorenal reciprocity

Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1386-1392

2003

Link zum Volltext

Verfügbarkeit prüfen

Measurements of renal glucose release

Diabetes (New York, N.Y.), 2001-04, Vol.50 (4), p.905-905

GERICH, John E

2001

Link zum Volltext

Verfügbarkeit prüfen

Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes

Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1386-1392

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

Diabetes (New York, N.Y.), 1982-08, Vol.31 (8 Pt 1), p.663

1982

Link zum Volltext

Verfügbarkeit prüfen

Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion

Diabetes (New York, N.Y.), 1983-02, Vol.32 (2), p.134

1983

Link zum Volltext

Verfügbarkeit prüfen

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

Diabetes (New York, N.Y.), 2002-02, Vol.51 (2), p.S117

Gerich, John E

2002

Link zum Volltext

Verfügbarkeit prüfen

Demonstration of a dawn phenomenon in normal human volunteers

Diabetes (New York, N.Y.), 1984-12, Vol.33 (12), p.1150

1984

Link zum Volltext

Verfügbarkeit prüfen

Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM

Diabetes (New York, N.Y.), 1990-02, Vol.39 (2), p.211

1990

Link zum Volltext

Verfügbarkeit prüfen

Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man

Diabetes (New York, N.Y.), 1981-06, Vol.30 (6), p.535

1981

Link zum Volltext

Verfügbarkeit prüfen

PRESERVE-[beta]: Two-Year Efficacy and Safety of Initial Combination Therapy with Nateglinide (NATE) or Glyburide (GLYB) Plus Metformin

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A66

2005

Link zum Volltext

Verfügbarkeit prüfen

Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell function

Diabetes (New York, N.Y.), 1980-09, Vol.29 (9), p.693

1980

Link zum Volltext

Verfügbarkeit prüfen

Hypoglycemia in IDDM

Diabetes (New York, N.Y.), 1989-09, Vol.38 (9), p.1193

1989

Link zum Volltext

Verfügbarkeit prüfen

Disturbances in [beta]-cell function in impaired fasting glycemia

Diabetes (New York, N.Y.), 2002-02, Vol.51 (2), p.S265

2002

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

Diabetes (New York, N.Y.), 1974-11, Vol.23 (11), p.876

1974

Link zum Volltext

Verfügbarkeit prüfen

Reduced Risk of Delayed Hypoglycemia with Nateglinide Compared to Repaglinide

Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A128

2000

Link zum Volltext

Verfügbarkeit prüfen

Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions

Diabetes/metabolism reviews, 1988-03, Vol.4 (2), p.93-111

1988

Link zum Volltext

Verfügbarkeit prüfen

Mechanism for underestimation of isotopically determined glucose disposal

Diabetes (New York, N.Y.), 1989-06, Vol.38 (6), p.744

1989

Link zum Volltext

Verfügbarkeit prüfen

Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus

Diabetes (New York, N.Y.), 1981-12, Vol.30 (12), p.990

1981

Link zum Volltext

Verfügbarkeit prüfen

Regulation of whole-body leucine metabolism with insulin during mixed-meal absorption in normal and diabetic humans

Diabetes (New York, N.Y.), 1988-05, Vol.37 (5), p.512

1988

Link zum Volltext

Verfügbarkeit prüfen

Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens

Diabetes (New York, N.Y.), 1987-03, Vol.36 (3), p.305

1987

Link zum Volltext

Verfügbarkeit prüfen

Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus

Diabetes (New York, N.Y.), 1985-06, Vol.34 (6), p.541

1985

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDiabetes

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Male
(24)
Adult
(21)
Insulin - Blood
(20)
Female
(18)
Biological And Medical Sciences
(16)
Blood Glucose - Metabolism
(13)
Blood Glucose - Analysis
(12)
Glucagon - Blood
(11)
Medical Sciences
(11)
Middle Aged
(11)
Endocrine Pancreas. Apud Cells
(9)
Endocrinology & Metabolism
(9)
Endocrinopathies
(9)
Glucose - Metabolism
(9)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Adolescent
(8)
Diabetes. Impaired Glucose Tolerance
(8)
Insulin Resistance
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Diabetes/metabolism Reviews
(1)
Diabetes;
(1)

Menü

Weitere Dienste

Einstellungen

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens

Disturbances in β-Cell Function in Impaired Fasting Glycemia

Role of the human kidney in glucose counterregulation

Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: Further evidence for hepatorenal reciprocity

Measurements of renal glucose release

Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

Demonstration of a dawn phenomenon in normal human volunteers

Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM

Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man

PRESERVE-[beta]: Two-Year Efficacy and Safety of Initial Combination Therapy with Nateglinide (NATE) or Glyburide (GLYB) Plus Metformin

Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell function

Hypoglycemia in IDDM

Disturbances in [beta]-cell function in impaired fasting glycemia

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

Reduced Risk of Delayed Hypoglycemia with Nateglinide Compared to Repaglinide

Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions

Mechanism for underestimation of isotopically determined glucose disposal

Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus

Regulation of whole-body leucine metabolism with insulin during mixed-meal absorption in normal and diabetic humans

Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens

Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus

Aktive Filter

Suchergebnisse filtern